OQS
LUNG icon

Occudo Quantitative Strategies’s Pulmonx LUNG Stock Holding History

Occudo Quantitative Strategies’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,232
Closed -$239K – 1170
2023
Q2 		$239K Buy
+18,232
New +$223K 0.02% 800
2023
Q1 		– Sell
-53,851
Closed -$454K – 1067
2022
Q4 		$454K Buy
+53,851
New +$512K 0.05% 534

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Occudo Quantitative Strategies's LUNG Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Pulmonx (LUNG) in Q3 2023, closing a stake of 18,232 shares — an estimated $239K sold.

Occudo Quantitative Strategies first reported a position in LUNG in Q4 2022 and held it in 2 quarters. The position peaked at $454K in Q4 2022. 117 funds tracked by Wall St. Rank hold LUNG as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Pulmonx position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 18,232 Pulmonx shares in Q3 2023, an estimated $239K.
  • Occudo Quantitative Strategies first reported a position in Pulmonx in Q4 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Pulmonx position peaked at $454K in Q4 2022.
  • 117 funds tracked by Wall St. Rank held Pulmonx as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.